Kun Qing Selected Research

Xenon-129

3/2024	Pulmonary MRI with hyperpolarized xenon-129 demonstrates novel alterations in gas transfer across the air-blood barrier in asthma.
10/2022	3D Single-Breath Chemical Shift Imaging Hyperpolarized Xe-129 MRI of Healthy, CF, IPF, and COPD Subjects.
3/2022	A pilot study of function-based radiation therapy planning for lung cancer using hyperpolarized xenon-129 ventilation MRI.
1/2021	Evaluation of Regional Lung Function in Pulmonary Fibrosis with Xenon-129 MRI.
1/2021	Characterisation of gas exchange in COPD with dissolved-phase hyperpolarised xenon-129 MRI.
1/2019	Using Hyperpolarized Xenon-129 MRI to Quantify Early-Stage Lung Disease in Smokers.
1/2019	Probing Changes in Lung Physiology in COPD Using CT, Perfusion MRI, and Hyperpolarized Xenon-129 MRI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kun Qing Research Topics

Disease

7	Chronic Obstructive Pulmonary Disease (COPD) 11/2023 - 01/2016
3	Asthma (Bronchial Asthma) 03/2024 - 01/2021
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2023 - 01/2021
2	Lung Diseases (Lung Disease) 10/2022 - 01/2019
1	Idiopathic Pulmonary Fibrosis 10/2022
1	Cystic Fibrosis (Mucoviscidosis) 10/2022
1	Lung Injury 03/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022
1	Lung Neoplasms (Lung Cancer) 03/2022
1	Neoplasms (Cancer) 01/2022
1	Emphysema 01/2021
1	Body Weight (Weight, Body) 01/2018

Drug/Important Bio-Agent (IBA)

7	Xenon-129IBA 03/2024 - 01/2019
2	XenonIBA 06/2023 - 05/2023
2	Carbon MonoxideIBA 01/2021 - 01/2019
1	diethylenetriamineIBA 11/2023
1	A 7 (A-7)IBA 10/2022
1	Helium-3IBA 01/2021
1	GadoliniumIBA 01/2019
1	Apolipoproteins E (ApoE)IBA 01/2018
1	Protons (Proton)IBA 01/2016

Therapy/Procedure

2	Radiotherapy 03/2022 - 01/2022